Company Filing History:
Years Active: 2019
Title: Rebecka Hellsten: Innovator in Cancer Treatment
Introduction
Rebecka Hellsten is a prominent inventor based in Limhamn, Sweden. She has made significant contributions to the field of cancer treatment through her innovative research and development.
Latest Patents
Rebecka holds 1 patent for her work on Ether analogues of galiellalactone. This patent discloses methods of preparing the analogues and their use in the treatment of cancer. The analogues are represented by specific formulas, which highlight their potential therapeutic applications.
Career Highlights
Rebecka is associated with Glactone Pharma Development AB, where she continues to advance her research in medicinal chemistry. Her work focuses on developing novel compounds that can improve cancer treatment outcomes.
Collaborations
Rebecka collaborates with notable colleagues, including Johansson Martin and Olov Sterner, to enhance the scope and impact of her research.
Conclusion
Rebecka Hellsten's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. Her contributions are paving the way for new therapeutic options in oncology.